Text Size

Retrospective Data Review of ReCap Total Hip Resurfacing

This study has been withdrawn prior to enrollment.
(No further contact with the site)
Sponsor:
Collaborator:
Biomet U.K. Ltd.
Information provided by (Responsible Party):
Biomet, Inc.
ClinicalTrials.gov Identifier:
NCT00758329
First received: September 23, 2008
Last updated: December 5, 2011
Last verified: November 2011
History of Changes
  Purpose

Retrospective Data Review on clinical outcomes and survivorship of ReCap Total Hip Resurfacing


Condition Intervention
Osteoarthritis of the Hip
 Device: ReCap Total Hip Resurfacing

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Retrospective Data Review of ReCap Total Hip Resurfacing

Resource links provided by NLM:

MedlinePlus related topics: Osteoarthritis
U.S. FDA Resources

Further study details as provided by Biomet, Inc.:

Primary Outcome Measures:
  • Survival rate [ Time Frame: 2 yr ] [ Designated as safety issue: Yes ]

Secondary Outcome Measures:
  • Harris Hip Score [ Time Frame: 2yr ] [ Designated as safety issue: No ]

Enrollment: 0
Study Start Date: April 2004
Study Completion Date: April 2010
Primary Completion Date: April 2010 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
1 Device: ReCap Total Hip Resurfacing
ReCap Total Hip Resurfacing

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Patients who received ReCap Total Hip Resurfacing

Criteria

Inclusion:

  • Patients received ReCap total hip resurfacing
  Contacts and Locations
No Contacts or Locations Provided
  More Information

No publications provided

Responsible Party: Biomet, Inc.
ClinicalTrials.gov Identifier: NCT00758329     History of Changes
Other Study ID Numbers: BMET UK 09
Study First Received: September 23, 2008
Last Updated: December 5, 2011
Health Authority: United Kingdom: Medicines and Healthcare Products Regulatory Agency

Additional relevant MeSH terms:
Osteoarthritis
Osteoarthritis, Hip
Arthritis
 Joint Diseases
Musculoskeletal Diseases
Rheumatic Diseases

ClinicalTrials.gov processed this record on June 18, 2013